Table 1.
DXA and pQCT analysis of Scl Ab treatment
DXA Whole Body Analysis | WT Veh (n = 11) | WT Scl Ab (n = 12) | TIEG KO Veh (n = 12) | TIEG KO Scl Ab (n = 12) | Treatment | Model | Interaction |
---|---|---|---|---|---|---|---|
Total Bone Mineral Density (g/cm2) | 0.057 ± 0.002 | 0.063 ± 0.001 | 0.057 ± 0.002 | 0.060 ± 0.001 | 0.0041 | NS | NS |
Total Bone Mineral Content (g) | 0.476 ± 0.019 | 0.550 ± 0.017 | 0.456 ± 0.020 | 0.506 ± 0.012 | 0.0005 | NS | NS |
pQCT Tibial Metaphysis Analysis | |||||||
Total Content (mg) | 1.45 ± 0.03 | 1.67 ± 0.04 | 1.37 ± 0.03 | 1.62 ± 0.02 | <0.0001 | 0.0266 | NS |
Total Density (mg/cm3) | 426 ± 9 | 500 ± 7 | 430 ± 6 | 506 ± 7 | <0.0001 | NS | NS |
Trabecular Content (mg) | 0.279 ± 0.008 | 0.239 ± 0.011 | 0.239 ± 0.011 | 0.230 ± 0.012 | 0.0105 | 0.0105 | NS |
Trabecular Density (mg/cm3) | 201 ± 3 | 208 ± 4 | 190 ± 4 | 207 ± 4 | NS | 0.0054 | NS |
Trabecular Area (mm2) | 1.40 ± 0.05 | 1.16 ± 0.04 | 1.25 ± 0.04 | 1.11 ± 0.04 | 0.0001 | 0.0334 | NS |
pQCT Tibial Diaphysis Analysis | |||||||
Total Content (mg) | 1.01 ± 0.03 | 1.13 ± 0.03 | 0.92 ± 0.01 | 1.06 ± 0.01 | <0.0001 | 0.0002 | NS |
Total Density (mg/cm3) | 734 ± 6 | 799 ± 7 | 736 ± 7 | 813 ± 7 | NS | <0.0001 | NS |
Cortical Content (mg) | 0.785 ± 0.020 | 0.906 ± 0.022 | 0.708 ± 0.014 | 0.853 ± 0.011 | <0.0001 | 0.0005 | NS |
Cortical Density (mg/cm3) | 1129 ± 5 | 1177 ± 5 | 1120 ± 5 | 1176 ± 4 | <0.0001 | NS | NS |
Cortical Area (mm2) | 0.696 ± 0.017 | 0.770 ± 0.017 | 0.631 ± 0.011 | 0.723 ± 0.009 | <0.0001 | 0.0002 | NS |
Cortical Thickness (mm) | 0.362 ± 0.009 (n=3) | 0.404 ± 0.007 (n=8) | 0.365 ± 0.004 (n=6) | 0.401 ± 0.009 (n=7) | NS | NS | NS |
Periosteal Circumference (mm) | 4.16 ± 0.05 | 4.21 ± 0.05 | 3.96 ± 0.03 | 4.04 ± 0.03 | NS | <0.0001 | NS |
Endosteal Circumference (mm) | 2.93 ± 0.04 | 2.83 ± 0.04 | 2.78 ± 0.03 | 2.69 ± 0.03 | <0.0001 | <0.0001 | <0.0001 |
Data expressed as mean ± SE. Two-way ANOVA reported as interaction. Significance in ANOVA for treatment or model are noted. Significance level p ≤ 0.05.